在老年人中,BMI和年龄之间的相互作用对老年人中跌倒风险的影响
Filipe Rodrigues1,2, Diogo Monteiro1,2, António Miguel Monteiro3,4
1ESECS-Polytechnic of Leiria, 2411-901 Leiria, Portugal.
Epidemiologia (Basel, Switzerland)
|February 20, 2026
概括
在60-79岁的老年人中,肥胖增加了跌倒风险. 然而,在80岁以上的人群中,正常体重可能无法防止因潜在的肌肉损失 (肉症) 而导致的跌倒.
科学领域:
- 老年学是指老年学的学科.
- 公共卫生 公共卫生
- 运动学 运动学
背景情况:
- 衰老与功能适应性降低和跌倒可能性增加有关.
- 肥胖是已知的行动能力下降的一个因素,但其与衰老和跌倒风险的相互作用需要进一步研究.
- 了解这些关系对于预防老年人跌倒至关重要.
研究的目的:
- 调查年龄,性别和体重指数 (BMI) 对社区老年人跌倒风险的综合影响.
- 确定特定的年龄组和BMI类别,在这些年龄组和BMI类别中,跌倒风险明显增加.
- 探索潜在的机制,如 Sarcopenia,有助于在晚年跌倒的风险.
主要方法:
- 一项对815名老年人 (平均年龄为70.45岁) 的横截面研究.
- 参与者按年龄 (60岁,70岁,80岁) 和BMI (正常,超重,肥胖) 分层.
- 跌倒风险是使用定时启动和启动测试来测量的,并使用三向ANOVA进行分析.
主要成果:
- 没有发现年龄,性别和BMI之间的显著相互作用,也没有发现性别对跌倒风险的主要影响.
- 观察到年龄和BMI之间的显著相互作用 (p=0.007).
- 与正常体重相比,肥胖在60岁和70岁的人群中显著增加了跌倒风险,但在80岁的人群中并非如此.
结论:
- 肥胖是60-79岁成年人中跌倒的重要风险因素之一.
- 在八十岁的人中存在一个"体重悖论",正常体重无法提供保护,可能是由于肉症.
- 建议根据年龄量身定制的跌倒风险评估和体重管理,强调老年人的肌肉质量保护.
相关概念视频
01:15Drug Dosing: Geriatric Patients
308
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
308
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
257
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
257
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
287
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
287
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
249
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
249
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
274
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
274
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
748
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
748